Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fry

Showing results (91-100 of 201) with videos related to

Pageof 21
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1983
Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytesD W Fry, D A Gewirtz, J C Yalowich, et al.
Biochemical Pharmacology|October 1, 1985
In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles)D W Fry, T J Boritzki, J A Besserer, et al.
Molecular and Cellular Biology|June 22, 1999
Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2J D Owen, P J Ruest, D W Fry, et al.
ACS Nano|May 27, 2010
An optical nanocavity incorporating a fluorescent organic dye having a high quality factorAli M Adawi, Mohamed M Murshidy, Paul W Fry, et al.
Cancer Research|July 1, 1980
Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3':5'-monophosphate in the Ehrlich ascites tumorJ C White, R A Carchman, D W Fry, et al.
Cancer Letters|June 1, 1986
Cross resistance of pleiotropically drug resistant P338 leukemia cells to the lipophilic antifolates trimetrexate and BW 301UW D Klohs, R W Steinkampf, J A Besserer, et al.
Seminars in Oncology|April 1, 1988
Preclinical studies with trimetrexate: a review of conclusions and unanswered questionsR C Jackson, W R Leopold, K L Hamelehle, et al.
Ethnicity & Disease|June 4, 2010
United States black:white infant mortality disparities are not inevitable: identification of community resilience independent of socioeconomic statusYvonne W Fry-Johnson, Robert Levine, Diane Rowley, et al.
JAMA|October 5, 1970
Toxicity following methoxyflurane anesthesia. 3. Hemodialysis of metabolitesD R Taves, A J Gillies, R B Freeman, et al.
Journal of Dental Research|June 1, 1984
Fluoride levels in dentin after iontophoresis of 2% NaFJ M Wilson, B W Fry, R E Walton, et al.
Pageof 21

Showing results (91-100 of 201) with videos related to

Sort By:
Pageof 21
Advances in Experimental Medicine and Biology|January 1, 1983
Characteristics of the accumulation of methotrexate polyglutamate derivatives in Ehrlich ascites tumor cells and isolated rat hepatocytesD W Fry, D A Gewirtz, J C Yalowich, et al.
Biochemical Pharmacology|October 1, 1985
In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles)D W Fry, T J Boritzki, J A Besserer, et al.
Molecular and Cellular Biology|June 22, 1999
Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2J D Owen, P J Ruest, D W Fry, et al.
ACS Nano|May 27, 2010
An optical nanocavity incorporating a fluorescent organic dye having a high quality factorAli M Adawi, Mohamed M Murshidy, Paul W Fry, et al.
Cancer Research|July 1, 1980
Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3':5'-monophosphate in the Ehrlich ascites tumorJ C White, R A Carchman, D W Fry, et al.
Cancer Letters|June 1, 1986
Cross resistance of pleiotropically drug resistant P338 leukemia cells to the lipophilic antifolates trimetrexate and BW 301UW D Klohs, R W Steinkampf, J A Besserer, et al.
Seminars in Oncology|April 1, 1988
Preclinical studies with trimetrexate: a review of conclusions and unanswered questionsR C Jackson, W R Leopold, K L Hamelehle, et al.
Ethnicity & Disease|June 4, 2010
United States black:white infant mortality disparities are not inevitable: identification of community resilience independent of socioeconomic statusYvonne W Fry-Johnson, Robert Levine, Diane Rowley, et al.
JAMA|October 5, 1970
Toxicity following methoxyflurane anesthesia. 3. Hemodialysis of metabolitesD R Taves, A J Gillies, R B Freeman, et al.
Journal of Dental Research|June 1, 1984
Fluoride levels in dentin after iontophoresis of 2% NaFJ M Wilson, B W Fry, R E Walton, et al.
Pageof 21